Vivani Medical (VANI) Change in Cash (2014 - 2026)
Vivani Medical (VANI) posted quarterly Change in Cash of $3.5 million for Q1 2026, up 165.81% year-over-year from $1.3 million in Q1 2025, and down 74.15% quarter-over-quarter from $13.6 million in Q4 2025.
Vivani Medical (VANI) Change in Cash (2014 - 2026) Analysis & Trends
Vivani Medical's Change in Cash history runs 13 years deep, the most recent figure standing at $3.5 million for Q1 2026.
- In Q1 2026, Change in Cash rose 165.81% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $6.7 million (up 140.51% YoY), while the FY2025 annual figure was -$2.1 million, up 7.91% from the prior year.
- Change in Cash for Q1 2026 stood at $3.5 million, down from $13.6 million in the prior quarter.
- The five-year high for Change in Cash was $48.2 million in Q3 2022, with the low at -$7.7 million in Q3 2023.
- The 5-year median for Change in Cash is -$4.2 million (2023), against an average of $1.1 million.
- The sharpest annual moves came in 2022 and 2025: Change in Cash slumped 623.15% in 2022, then soared 1151.31% in 2025.
- Vivani Medical's Change in Cash stood at -$5.2 million in 2022, then rose by 19.97% to -$4.2 million in 2023, then jumped by 69.15% to -$1.3 million in 2024, then jumped by 1151.31% to $13.6 million in 2025, then slumped by 74.15% to $3.5 million in 2026.
- Business Quant data shows VANI's Change in Cash at $3.5 million in Q1 2026, $13.6 million in Q4 2025, and -$4.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | -301,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -301,000.00 |
| Mar 31, 2026 | 3.52 Mn |
| Dec 31, 2025 | 13.60 Mn |
| Sep 30, 2025 | -4.17 Mn |
| Jun 30, 2025 | -6.21 Mn |
| Mar 31, 2025 | -5.34 Mn |
| Dec 31, 2024 | -1.29 Mn |
| Sep 30, 2024 | -5.27 Mn |
| Jun 30, 2024 | -4.73 Mn |
| Mar 31, 2024 | 8.99 Mn |
| Dec 31, 2023 | -4.20 Mn |
| Sep 30, 2023 | -7.67 Mn |
| Jun 30, 2023 | -5.59 Mn |
| Mar 31, 2023 | -7.00 Mn |
| Dec 31, 2022 | -5.24 Mn |
| Sep 30, 2022 | 48.23 Mn |
| Jun 30, 2022 | -3.52 Mn |
| Mar 31, 2022 | 4.80 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | -71.57 Mn |